TESTING
TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE
By Imogen
Evans, Hazel Thornton, and Iain Chalmers
REFERENCES 61-90
61 Goodare H. Studies that do not have informed consent from
participants should not
be published. In: Doyal L, Tobias JS, eds. Informed consent in medical
research. BMJ
Books 2001, pp131–3.
62 Fallowfield L, Jenkins V, Farewell V, et al. Efficacy of a Cancer
Research UK
communicating skills training model for oncologists: a randomised
controlled trial.
Lancet 2002;359:650–6.
63 Tobias J, Souhami R. Fully informed consent can be needlessly cruel.
British Medical
Journal 1993;307:119–20.
64 Baum, M. The ethics of randomised controlled trials. European
Journal of Surgical
Oncology 1995;21:136–7.
65 Thornton H. Why do we need clinical trials? BACUP News; issue 30,
autumn 1997, p7.
66 de Takats P, Harrison J. Clinical trials and stroke. Lancet
1999;353:150.
67 Chalmers I, Lindley R. Double standards on informed consent to
treatment. In: Doyal L, Tobias JS, eds. Informed consent in medical
research. London: BMJ Books 2001, pp266–75.
68 Ashcroft, R. Giving medicine a fair trial. British Medical Journal
2000;320:1686.
69 Savulescu J, Chalmers I, Blunt J. Are research ethics committees
behaving unethically? Some suggestions for improving performance and
accountability. British Medical Journal 1996;313:1390–3.
70 European Carotid Surgery Trialists’ Collaborative Group. Randomised
trial of endarterectomy for recently symptomatic carotid stenosis:
final results of the MRC European Carotid Surgery Trial (ECST). Lancet
1998;351:1379–87.
71 Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic
carotid
stenosis. The Cochrane Database of Systematic Reviews 1999, Issue 3.
Art. No.:
CD001081. Available from: www.thecochranelibrary.com [accessed 3 January
2006].
72 The Magpie Trial Collaborative Group. Do women with pre-eclampsia,
and their babies, benefit from magnesium sulphate? The Magpie Trial: a
randomised, placebocontrolled trial. Lancet 2002;359:1877–90.
73 Duley L, Gu¨ lmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and
other
anticonvulsants for women with pre-eclampsia. The Cochrane Database of
Systematic Reviews 2003, Issue 2. Art. No.: CD000025. Available from:
www.thecochranelibrary.com [accessed 3 January 2006].
74 Grimwade K, Swingler, G, Grimley Evans J. Cotrimoxazole prophylaxis
for opportunistic infections in adults with HIV. The Cochrane Database
of Systematic Reviews 2003, Issue 3. Art. No.: CD003108. Available
from: www.thecochranelibrary.com [accessed 3 Jan. 2006].
75 Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis
against
opportunistic infections in HIV-infected Zambian children (CHAP): a
double blind
randomised placebo-controlled trial. Lancet 2004;364:1865–71.
76 MRC News Release. Antibiotic drug almost halves AIDS-related death
in children.
London: MRC, November 19, 2004.
77 Soares K, McGrath J, Adams C. Evidence and tardive dyskinesia. Lancet
1996;347:1696–7.
78 Thornley B, Adams C. Content and quality of 2000 controlled trials
in schizophrenia
over 50 years. British Medical Journal 1998;317:1181–4.
79 Howell CJ, Chalmers I. A review of prospectively controlled
comparisons of epidural
with non-epidural forms of pain relief during labour. International
Journal of Obstetric
Anesthesia 1992;1:93–110.
80 Chan A-W, Hro´ bjartsson A, Haahr MT, Gøtzsche PC, Altman DG.
Empirical evidence for selective reporting of outcomes in randomized
trials: comparison of protocols to published articles. Journal of the
American Medical Association 2004;291:2457–65.
81 Horn J, de Haan RJ, Vermeulen RD, Luiten PGM, Limburg M. Nimodipine
in animal model experiments of focal cerebral ischemia: a systematic
review. Stroke 2001;32:2433–8.
82 Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical
trials builds evidence of exemplary clinical practice. Journal of
Clinical Epidemiology 1995;48: 45–57.
83 Altman DG. The scandal of poor medical research. British Medical
Journal 1994;308:283–4.
84 Tallon D, Chard J, Dieppe P. Relation between agendas of the
research community and the research consumer. Lancet 2000;355:2037–40.
85 Cream J, Cayton H. New drugs for Alzheimer’s disease – a consumer
perspective. CPD Bulletin Old Age Psychiatry 2001;2:80–2.
86 Cohen CI, D’Onofrio A, Larkin L, Berkholder P, Fishman H. A
comparison of consumer and provider preferences for research on
homeless veterans. Community Mental Health Journal 1999;35:273–9.
87 Griffiths KM, Jorm AF, Christensen H, et al. Research priorities in
mental health, Part 2: an evaluation of the current research effort
against stakeholders’ priorities. Australian and New Zealand Journal of
Psychiatry 2002;36:327–39.
88 Chalmers I. Current controlled trials: an opportunity to help
improve the quality of clinical research. Current Controlled Trials in
Cardiovascular Medicine 2000;1:3–8. Available from :
http://cvm.controlled-trials.com/content/1/1/3 [accessed 12 December
2005].
89 Safeguarding participants in controlled trials [Editorial]. Lancet
2000;355:1455–63.
90 Weatherall D. Academia and industry: increasingly uneasy bedfellows.
Lancet 2000;355:1574.
|
